What’s driving pharma’s layoffs in 2025
PharmaVoice
MARCH 10, 2025
Familiar foes in the industry have claimed a slew of jobs in recent months.
Trending Articles
285 
What If Part of the $500 Billion AI Allocation Was Focused On Women’s Health?
MedCity News
MARCH 11, 2025
With $500 billion allocated to the Stargate initiative, just imagine what could be done if 10% of that focused on women, who make up 51% of the population. The post What If Part of the $500 Billion AI Allocation Was Focused On Womens Health? appeared first on MedCity News.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy
MedCity News
MARCH 7, 2025
J&J said aticaprant showed insufficient efficacy in a Phase 3 test in major depressive disorder. The disappointing result follows the Phase 3 failure of a Neumora Therapeutics drug that addresses the same central nervous system target. The post Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy appeared first on MedCity News.
How to Succeed as a Clinical Specialist in Medical Sales With Gina Torres
Evolve Your Success
MARCH 12, 2025
Breaking Into Medical Sales: Gina Torres’s Journey from Nurse to Industry Expert In this inspiring episode, Gina Torres, a seasoned peripheral vascular representative, shares her incredible transition from a peripheral vascular nurse to a top medical device sales expert at Shockwave. Discover how she leveraged her clinical background to drive innovation and improve patient outcomes, particularly in preventing amputations for those with peripheral arterial disease.
The Intersection of AI and Sales: Personalization Without Compromise
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
AstraZeneca and Ionis win EU approval for ATTR polyneuropathy
Pharmaceutical Technology
MARCH 10, 2025
AstraZeneca and Ionis are intensifying their competition with Alnylam by securing an EU approval for Wainzua.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
As tariffs loom over pharma manufacturing, a reshoring effort is underway — but not without challenges
PharmaVoice
MARCH 10, 2025
Experts say cost and other barriers present challenges to returning to U.S. shores.
Inside Healthcare’s Hottest New AI Category: Agentic AI
MedCity News
MARCH 9, 2025
Healthcare organizations are starting to implement AI agents autonomous, task-specific systems designed to perform functions with little or no human intervention. While initial adoption is focused mainly on non-clinical areas like scheduling and prior authorizations, experts predict that AI agents could eventually play a role in clinical decision-making, provided they meet rigorous safety and reliability standards.
Full Tolerance Coverage Method for Assessing Uniformity of Dosage Units with Large Sample Sizes
PharmaTech
MARCH 10, 2025
The full tolerance coverage method is introduced as a coverage estimation approach for assessing the uniformity of dosage units from large sample sizes, ensuring that no dosage unit exceeds the specification range.
NHS patients receive UK-donated plasma medicines for first time in 30 years
PharmaTimes
MARCH 6, 2025
Octapharma supports NHS in building resilient supply chain
5 Ways You Can Win Faster with Gen AI in Sales
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
GenAI and the revolution of drug development
pharmaphorum
MARCH 6, 2025
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Bryan Hill, life sciences chief technology officer at Cognizant, in a conversation on how generative AI is revolutionising life sciences and drug development.
The first new type of drug for Tourette syndrome in over 50 years is close to the FDA’s doorstep
PharmaVoice
MARCH 11, 2025
Emalex Biosciences is full steam ahead with a targeted 2026 approval and launch for its novel drug.
Enhancing Medical Education through Gamification and Innovative Technologies
Impetus Digital
MARCH 6, 2025
A version of this article was previously published on PharmaPhorum. As the demands of modern healthcare grow, new therapies are introduced at record speeds, and guidelines are quickly updated, it is key that medical education evolves to keep up. Traditional medical educationreliant on didactic presentations with limited opportunity for interactionis plagued by a range of issues, including suboptimal participation and no or poor personalisation ability.
New weight-loss pill shows promising results
PharmaTimes
MARCH 11, 2025
Oxford Medical Products targets overweight individuals
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Roche builds in obesity with $5.3bn Zealand licensing deal
pharmaphorum
MARCH 12, 2025
Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma.
Pricing transparency is in the spotlight — and that could be good news for drugmakers
PharmaVoice
MARCH 11, 2025
An opaque system of rebates and discounts makes understanding a drug’s true price near impossible, even for experts. Can efforts to bring transparency into that system now pan out?
Roche Puts Up $1.65B to Partner With Zealand on ‘Future Foundational Therapy’ for Obesity
MedCity News
MARCH 12, 2025
Roche will share in developing and commercializing petrelintide, a clinical-stage Zealand Pharma drug that activates the amylin receptor to spark weight loss. This agreement represents the highest total financial consideration in the obesity field to date. The post Roche Puts Up $1.65B to Partner With Zealand on Future Foundational Therapy for Obesity appeared first on MedCity News.
Bristol Myers Squibb to acquire 2seventy bio
European Pharmaceutical Review
MARCH 11, 2025
Bristol Myers Squibb has agreed a merger with 2seventy bio in a deal worth approximately $286 million. A year ago, 2seventy decided to exclusively focus on unlocking the value of Abecma, with the goal of delivering more time for people living with multiple myeloma and maximizing value for all stakeholders, stated Chip Baird, Chief Executive Officer, 2seventy bio.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Artificial intelligence is making clinical supply chains more efficient and more sustainable: here’s how
Pharmaceutical Technology
MARCH 10, 2025
The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.
Gates-backed game aims to raise HPV awareness in Africa
pharmaphorum
MARCH 12, 2025
Psyon is running a pilot study of a game that aims to raise awareness of HPV infection and vaccination in sub-Saharan Africa.
Navigating human errors in medical device usage: Insights from human factors research
PharmaVoice
MARCH 10, 2025
Even the most advanced medical devices can fail patients if used incorrectly. These are the most common errors.
4 Prescription Drug Trends that are Top of Mind for One Abarca Exec
MedCity News
MARCH 11, 2025
Abarca Health is paying attention to specialty drugs, AI in healthcare, the impact of obesity-related conditions, and increased government regulations. The post 4 Prescription Drug Trends that are Top of Mind for One Abarca Exec appeared first on MedCity News.
Design Quality in Pharmaceutical Design: A Primer for Facility Executives
PharmaTech
MARCH 7, 2025
Being fully versed on the ins and outs of design quality can improve the project design phase life cycle.
Dementia drug neflamapimod shows positive phase 2b trial results
PharmaTimes
MARCH 11, 2025
CervoMed's therapy demonstrates significant improvement in patients
BMS absorbs CAR-T partner 2seventy bio for $286m
pharmaphorum
MARCH 11, 2025
Bristol Myers Squibb has moved to take full control of the CAR-T therapy it partners with 2seventy bio, agreeing to buy the biotech for around $286m
The time is ripe for pharma M&A. Why are drugmakers holding out?
PharmaVoice
MARCH 6, 2025
The M&A resurgence has been predicted for years, but the industry is still holding out, partly because the ideal range for biotech valuations has been harder to find.
AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Buprenorphine Access Still Lags, Even After Major Federal Policy Changes
MedCity News
MARCH 9, 2025
While the drop in drug overdose deaths is promising, and could potentially be partially attributed to the efforts of the federal government, we must remain cognizant about the sheer number of lives we continue to lose every year to overdose. The post Buprenorphine Access Still Lags, Even After Major Federal Policy Changes appeared first on MedCity News.
ElevateBio taps Amazon’s genAI tools to design CRISPR therapeutics
Pharmaceutical Technology
MARCH 11, 2025
AWSs framework will speed up the analysis of ElevateBios large protein datasets, hinting at promising drug candidates.
Leqembi enters second consultation period following NICE draft guidance update
PharmaTimes
MARCH 6, 2025
NICE convenes third committee meeting for additional appraisal consideration
Let's personalize your content